← Leaderboards
Mary E Marquart
Louisiana State Univ Hsc New Orleans
$2,873,558
Attributed
$3,086,683
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $693.4K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,086,683 · 5
By mechanism
R01$1,457,591 · 1
R21$845,525 · 2
R56$693,423 · 1
F32$90,144 · 1
Top collaborators
- Brian J. Akerley1 shared
Others in their field
Top investigators on “Pathogenesis”
- Jeffrey P Krischer · University Of South Florida$473,867,135
- Constance Ann Benson · University Of California, San Diego$309,631,408
- Daniel R Kuritzkes · Brigham And Women'S Hospital$212,627,101
- Richard K. Wilson · Washington University$203,917,615
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$198,007,440
- Carol Nesel · Westat$147,274,423
Research focus
PathogenesisBacteriaIn VitroVirulence FactorsAntibioticsVirulenceOryctolagus CuniculusInfectionKeratitisOrganismEye InfectionsEndophthalmitisLeadVisionStreptococcus PneumoniaeResistancePathogenMutantMediatingInflammationAntibodiesEpithelial CellsAntibiotic TherapyCells
Grant awards (12)
Multivalent antibody cocktail for bacterial endophthalmitis$693,423
R56 · FY2025 · EY · contact PI
Mechanisms underlying adhesion and colonization in pneumococcal keratitis$426,250
R21 · FY2023 · EY · contact PI
Characterization of viridans group streptococci from endophthalmitis$225,525
R21 · FY2021 · EY · contact PI
Characterization of viridans group streptococci from endophthalmitis$193,750
R21 · FY2020 · EY · contact PI
Streptococcus pneumoniae ocular pathogenesis and therapy$240,451
R01 · FY2011 · EY · contact PI
Streptococcus pneumoniae ocular pathogenesis and therapy$250,470
R01 · FY2010 · EY · contact PI
Streptococcus pneumoniae ocular pathogenesis and therapy$335,880
R01 · FY2009 · EY · contact PI
Streptococcus pneumoniae ocular pathogenesis and therapy$329,162
R01 · FY2008 · EY · contact PI
Streptococcus pneumoniae ocular pathogenesis and therapy$246,375
R01 · FY2007 · EY · contact PI
Streptococcus pneumoniae ocular pathogenesis and therapy$55,253
R01 · FY2007 · EY · contact PI
Pseudomonas proteases as ocular virulence factors$48,148
F32 · FY2002 · EY
Pseudomonas proteases as ocular virulence factors$41,996
F32 · FY2001 · EY